In vitro susceptibility of enterococci strains isolated from urine samples to fosfomycin and other antibiotics

Journal of Infection and Chemotherapy

Volumn 17, Issue 4, 2011, Pages 575-578

  Butcu, Mehmet ^a   Akcay, Seniha Senbayrak ^a   Inan, Asuman Sengoz ^a   Aksaray, Sebahat ^a   Engin, Derya Ozturk ^a   Calisici, Gulcin ^a  

^a GATA HAYDARPASA TRAINING HOSPITAL   (Turkey)

Author keywords

Enterococcus spp.; Fosfomycin susceptibility; Urinary tract infections

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; CIPROFLOXACIN; FOSFOMYCIN; GENTAMICIN; LEVOFLOXACIN; NITROFURANTOIN; NORFLOXACIN; PENICILLIN G; TEICOPLANIN; TETRACYCLINE; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; DISK DIFFUSION; ENTEROCOCCUS; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; EPSILOMETER TEST; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; SPECIES DISTRIBUTION; SPECIES IDENTIFICATION; TURKEY (REPUBLIC); URINALYSIS; URINARY TRACT INFECTION;

EID: 80052860052     PISSN: 1341321X     EISSN: 14377780     Source Type: Journal    
DOI: 10.1007/s10156-011-0212-7     Document Type: Article

References (15)

1. Arias AC, Murray BE. Enterococcus species, Streptococcus bovis group and Leuconostoc species. In: Mandell GL, Bennet JE, Dolin R, editors. Principles and practice of Infectious disease, vol 2, 7th ed. Amsterdam: Elsevier/Churchill Livingstone; 2010. pp. 2643-53.
2. SS Patel SA Balfour HM Bryson 1997 Fosfomycin tromethamine: a review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy as a single-dose oral treatment for acute uncomplicated lower urinary tract infections Drugs 53 4 637 656 9098664 10.2165/00003495-199753040-00007 1:CAS:528:DyaK2sXisFGgurs%3D (Pubitemid 27145957)
3. R Maviglia R Nestorini MA Pennisi 2009 Role of old antibiotics in multidrug resistant bacterial infections Curr Drug Targets 10 895 905 19799544 10.2174/138945009789108846 1:CAS:528:DC%2BD1MXhtFehtLbI
4. O Baylan 2010 Fosfomycin: past, present and future Mikrobiyol Bul 44 2 311 321 20549968
5. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. In: 19th informational supplement, M100-S18. Wayne, PA: CLSI; 2009.
6. GS Simonsen L Smabrekke DL Monnet TL Sørensen JK Møller KG Kristinsson A Lagerqvist-Widh, et al. 2003 Prevalence of resistance to ampicillin, gentamicin and vancomycin in Enterococcus faecalis isolates from clinical specimens and use of antimicrobials in five Nordic hospitals J Antimicrob Chemother 51 2 323 331 12562698 10.1093/jac/dkg052 1:CAS:528:DC%2BD3sXovFeitw%3D%3D (Pubitemid 36231152)
7. MA Phaller RN Jones GV Doern K Kugler The Sentry Participants Group 1998 Bacterial pathogens isolates from patient with bloodstream infection: frequencies of occurences and antimicrobial susceptibility patterns from the SENTRY antimicrobial surveillance program (United States and Canada, 1997) Antimicrob Agents Chemother 7 1762 1770 (Pubitemid 28311576)
8. R Daza J Gutierrez G Piedrola 2001 Antibiotic susceptibility of bacterial strains isolated from patients with community-acquired urinary tract infections Int J Antimicrob Agents 18 211 215 11673032 10.1016/S0924-8579(01)00389-2 1:CAS:528:DC%2BD3MXnslWlsb8%3D (Pubitemid 32979192)
9. B Kaçmaz A Aksoy 2005 Antimicrobial resistance of enterococci in Turkey Int J Antimicrob Agents 25 535 538 15908184 10.1016/j.ijantimicag.2005. 02.020 (Pubitemid 40732609)
10. D Quinones P Goni MC Rubio E Duran R Gómez-Lus 2005 Enterococcus spp. isolated from Cuba; species frequency of occurrence and antimicrobial susceptibility profile Diagn Microbiol Infect Dis 51 1 63 67 15629231 10.1016/j.diagmicrobio.2004.08.018 1:CAS:528:DC%2BD2MXktlSl (Pubitemid 40040570)
11. PC Fuchs AL Barry SD Brown 1999 Fosfomycin tromethamine susceptibility of outpatient urine isolates of Escherichia coli and Enterococcus faecalis from ten North American medical centres by three methods J Antimicrob Chemother 43 1 137 140 10381112 10.1093/jac/43.1.137 1:CAS:528:DyaK1MXhtFGktr8%3D (Pubitemid 29045943)
12. F Cilli H Pullukcu S Aydemir OR Sipahi M Tasbakan 2008 In vitro activity of fosfomycin tromethamine and linezolid against vancomycin-resistant Enterococcus faecium isolates Int J Antimicrob Agents 31 290 298 10.1016/j.ijantimicag.2007.11.003
13. F Allerberger I Klare 1999 In vitro activity of fosfomycin against vancomycin-resistant enterococci J Antimicrob Chemother 43 2 211 217 11252326 10.1093/jac/43.2.211 1:CAS:528:DyaK1MXhsFyms74%3D (Pubitemid 29082445)
14. MB Perri E Hershberger M Lonescu C Lauter MJ Zervos 2002 In vitro susceptibility of vancomycin-resistant enterococci (VRE) to fosfomycin Diagn Microbiol Infect Dis 42 269 271 12007445 10.1016/S0732-8893(02)00370-X 1:CAS:528:DC%2BD38Xjtl2ns70%3D (Pubitemid 34455018)
15. Shrestha NK, Chua JD, Tuohy MJ, Wilson DA, Procop GW, Longworth DL, et al. Antimicrobial susceptibility of vancomycin-resistant Enterococcus faecium: potential utility of fosfomycin. Scand J Infect Dis. 2003;35:12-4. (Pubitemid 36336360)